Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

But they have prioritized becoming more than middlemen by also becoming cancer care providers. Just as in other parts of health care that are vertically integrated, there is a large opportunity to ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is ...

endangering patients,” said the FTC's Chair, Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinises the practices of opaque drug middlemen.” ...

Evidence also suggests that some of the prescription drug rebates negotiated ... “I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary ...

The same day I reported that the Federal Trade Commission was investigating three major pharmacy benefit managers – the middlemen companies that help set drug prices – the FTC brought legal ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...